Dr. Gandy said in his private practice he tells patients that “no one was improved by Aduhelm and patients’ cognition always continued to decline at some rate.”Image The F.D.A. recently approved Aduhelm despite scant evidence that it helps patients. In a recent survey of nearly 200 neurologists and primary care doctors, most said they disagreed with the F.D.A. decision and did not plan to prescribe the drug to their patients. Dr. Gandy said that one patient in his private practice had to drop out because the patient suffered 10 brain microhemorrhages.

Source: New York Times July 14, 2021 23:15 UTC